Mayo Clinic settles multiyear dispute with Minnesota AG over charity care policies
The nonprofit health system did not admit to wrongdoing as part of the settlement, nor will it pay a financial penalty.
Dr. Oz vows to scrutinize Medicare Advantage as CMS head
Dr. Mehmet Oz, who has previously advocated for expanding the privatized Medicare program, said he would tackle upcoding among MA plans if confirmed.
MedPAC’s 2026 recommendations tie physician pay to Medicare Economic Index
Industry groups mostly supported the proposal to link payment increases for physicians to the practice cost of inflation minus 1 percentage point.
Dr. Oz stresses need for faster Medicare coverage of new devices during confirmation hearing
Mehmet Oz, President Trump’s pick to lead the CMS, said Medicare beneficiaries should have quicker access to new medical devices once they’re FDA-approved.
CMS nominee Oz says he supports Medicaid work requirements
Republicans are considering tying eligibility in the safety-net program to work, volunteer or education hours to meet spending targets.
Nevada announces intent to award Medicaid contracts
The Silver State plans to award managed care contracts to incumbents UnitedHealth, Elevance, Centene and Molina — along with CareSource, a newcomer to the state.
Navigating the 2024 proposed HIPAA security rule amendments
A new proposed rule aims to significantly amend the HIPAA security rule — these are the key updates to know.
Google Cloud’s head of healthcare on the state of AI
Aashima Gupta leads health tech projects for the massive cloud computing company. Here, she shares why she’s excited about advances in artificial intelligence and what’s coming down the pike for Google’s AI products.
Cigna reshuffles C-suite amid rising costs
Cigna promoted Brian Evanko to chief operating officer and named a new chief financial officer in his place, while Eric Palmer will be leaving the company as an apparent victim of the restructuring.
CMMI cancels 4 payment models early
The CMS estimates terminating the models will save nearly $750 million. The agency will also no longer implement two demonstrations that aimed to improve prescription drug affordability and access.